Body composition & metabolic risk, Johannesburg
Visceral fat and metabolic risk.
Where fat is stored matters as much as how much of it there is. Visceral fat around the abdominal organs carries more metabolic risk than fat stored under the skin.
In short
Visceral adipose tissue is fat stored around the abdominal organs, and it is more strongly associated with insulin resistance and cardiometabolic risk than subcutaneous fat alone. It cannot be judged reliably by appearance. Waist circumference, waist-to-height ratio and body-composition analysis give practical estimates and are useful for tracking change, while CT and MRI quantify visceral fat more directly but are not routine longevity screening tools. Bioelectrical impedance devices, including InBody, provide a reasonable estimate and trend rather than an exact measurement.
Medically reviewed by Dr Arnav Kapur, MBBCh Cum Laude
The approach
Understand first. Then treat.
Two people can weigh the same and carry very different metabolic risk. Fat stored around the liver, pancreas and intestines is metabolically active and drains into the portal circulation, which is part of why it is linked more closely to insulin resistance, dyslipidaemia, raised blood pressure and fatty liver than fat stored on the hips and thighs.
Because visceral fat cannot be seen directly, assessment relies on estimates. The practical approach is to combine a simple waist measurement with body-composition analysis and the rest of the metabolic picture, then use repeat measurements over time to judge whether treatment is working.
What we assess
- Waist circumference and waist-to-height ratio
- Weight, BMI and weight trajectory over time
- Body-composition analysis, including fat mass, skeletal muscle and visceral fat estimate
- Blood pressure
- Fasting glucose and HbA1c
- Full lipid panel, particularly triglycerides and HDL cholesterol
- Liver enzymes and assessment for metabolic dysfunction-associated steatotic liver disease where relevant
- Nutrition, alcohol intake, physical activity and sleep
- Medication that may affect weight or fat distribution
Why fat distribution matters
Visceral adipose tissue behaves differently from subcutaneous fat. It is more metabolically active, releases free fatty acids and inflammatory signals into the portal circulation and is associated with hepatic fat accumulation. Across large studies, central adiposity tracks cardiometabolic risk more closely than BMI does, which is why waist measurement adds information even when weight looks acceptable. Ethnicity influences the thresholds at which risk rises, so waist cut-offs are not identical for all populations.
How visceral fat is estimated
A tape measure remains genuinely useful: waist circumference and waist-to-height ratio are simple, reproducible and well validated against risk. Bioelectrical impedance devices, including InBody, estimate fat mass, muscle mass and a visceral fat figure from body water and impedance modelling. This is practical and good for tracking trends under consistent conditions, but the visceral fat number it reports is a modelled estimate, not a direct measurement, and should not be treated as an exact quantity. CT and MRI measure visceral fat area directly and are the reference methods, but they involve cost, and in CT's case radiation, and are not appropriate as routine screening. DEXA sits between the two.
Visceral fat, insulin resistance and cardiovascular risk
Visceral adiposity is one of the most consistent companions of insulin resistance. It frequently accompanies raised triglycerides, lower HDL cholesterol, raised blood pressure, higher fasting glucose and fatty liver, and it is associated with a higher risk of type 2 diabetes and cardiovascular disease. Association is not the same as proof of cause in every individual, and a visceral fat estimate does not replace glucose, lipid and blood-pressure assessment. It is useful because it helps explain why risk is present and gives a target that responds measurably to treatment.
How visceral fat changes with lifestyle and weight treatment
Visceral fat tends to respond earlier and proportionally more than total body fat during weight loss, which is part of why modest weight reduction improves glucose, triglycerides and blood pressure sooner than expected. Regular aerobic activity reduces visceral fat even where weight changes little, and resistance training protects the muscle mass that should be preserved during any weight loss. Reducing alcohol, improving sleep and treating sleep apnoea all contribute. Where treatment is clinically indicated, medical weight management, including GLP-1-based therapy in appropriate patients, can reduce visceral fat as part of overall fat loss. Progress is best judged on repeated waist and body-composition measurements taken under consistent conditions rather than on a single reading.
Common questions
Answers before you book.
Can thin people have high visceral fat?
Yes. Someone with a normal BMI can still carry a disproportionate amount of fat around the abdominal organs, sometimes with reduced muscle mass alongside it. This is why waist measurement, body composition and metabolic blood tests are more informative than weight alone.
Is belly fat always visceral fat?
No. Abdominal fat includes both subcutaneous fat, under the skin and easy to pinch, and visceral fat, deeper and around the organs. Appearance cannot reliably separate them, which is why estimation uses waist measurement and body-composition analysis rather than inspection.
How accurate is InBody for visceral fat?
It is useful for estimating and tracking, not for precise quantification. Bioelectrical impedance derives its visceral fat figure from a model, and results shift with hydration, food, exercise and time of day. Measured consistently, the trend is meaningful; the absolute number should not be read as an exact visceral fat volume. CT and MRI remain the reference methods where direct quantification is genuinely needed.
Can visceral fat be reduced?
Yes, and often more readily than total body fat. Weight loss, regular aerobic exercise, resistance training, reduced alcohol intake and better sleep all reduce it, and medical weight management can help where it is clinically appropriate. There is no evidence that targeted abdominal exercises specifically remove visceral fat.
This page provides general health information and does not replace individual medical assessment. Body-composition estimates are interpreted alongside clinical findings and established metabolic testing, and treatment is selected according to individual circumstances.
Ready to start properly?
- Insulin resistance and metabolic health
- Medical Weight Management
- Metabolic Health & Diabetes
- Diagnostics
- Longevity & Preventative Medicine
- Book a consultation
Centre of Advanced Medicine, 13 Scott St, Waverley, Johannesburg
Monday to Friday, 07:40 to 17:00
011 440 8721